Bleeding experience with medication abortion prior to embryonic cardiac activity

Area of Science:

• Reproductive Health
• Medical Abortion Research
• Patient Experience Studies

Background:

• Medication abortion is a common early pregnancy termination method.
• Gestational duration significantly influences medication abortion experiences.
• Limited data exists on patient experiences before embryonic cardiac activity (ECA) detection.

Purpose of the Study:

• To characterize the patient experience with early medication abortion (prior to ECA detection).
• To assess bleeding, cramping, pregnancy symptoms, functional recovery, and efficacy.
• To identify factors influencing patient experience in early medication abortion.

Main Methods:

• Prospective cohort study design.
• Eight electronic surveys administered from abortion initiation to six weeks.
• Chart abstraction for demographic and clinical data.
• Descriptive statistics and bivariate analyses.

Main Results:

• 250 participants enrolled; 63.1% reported heavier bleeding than menses and 71.6% heavier cramping in the first three days.
• Nulliparity and crown rump length (CRL) were associated with increased cramping.
• 39.5% of those with baseline pregnancy symptoms still experienced them at two weeks.
• Mean functional recovery time was 5.8 days with low complication rates.

Conclusions:

• Medication abortion before ECA detection is associated with less frequent heavy bleeding and cramping compared to later first-trimester abortions.
• Counseling can be adjusted to manage patient expectations regarding bleeding and cramping intensity.
• Tailored counseling and follow-up are recommended given increasing access to very early gestational duration (GD) abortion care due to bans at ECA.